Meanwhile, changes in quality-of-life scores measured by the Short Form-36 (SF-36) physical and mental components were small and not clinically significant across groups [1]
(27) The benefits of GLP-1 agonists were observed across various subgroups, including males and females, individuals younger than 70 years, and patients with varying diabetes durations
The Lewis lung carcinoma (LLC) model is the only reproducible syngeneic model for NSCLC [15]
3C), INS-1 and MIN6 cells (Fig
We used total TIRF microscopy to study the mean near-membrane granule trafficking [24]
Traditional growth hormone therapy carries risks including fluid retention, joint pain (paradoxically), carpal tunnel syndrome, and increased cancer risk